Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-02-28 @ 10:01 PM
Study NCT ID:
NCT03749018
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-02
First Post:
2018-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
Sponsor:
David Bond, MD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Aggressive Non-Hodgkin Lymphoma | View |
| None | Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell … | View |
| None | Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma | View |
| None | Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell … | View |
| None | Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma | View |
| None | Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell … | View |
| None | Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | View |
| None | Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell … | View |
| None | Diffuse Large B-Cell Lymphoma | View |
| None | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 … | View |
| None | High Grade B-Cell Lymphoma, Not Otherwise Specified | View |
| None | Indolent Non-Hodgkin Lymphoma | View |
| None | Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large … | View |
| None | Transformed Non-Hodgkin Lymphoma | View |
Keywords: